Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX

End-of-day quote. End-of-day quote  - 05/22
7.68 USD   +7.56%
11/06DJLexicon, Sanofi Agree to Diabetes Drug Pact
11/06 LEXICON PHARMAC : reports 3Q loss
11/06 Sanofi sees strong profit growth from 2018, to cut costs
Financials ($)
Sales 2015 3,08 M
EBIT 2015 -117 M
Net income 2015 -125 M
Debt 2015 50,0 M
Yield 2015 -
Sales 2016 52,4 M
EBIT 2016 -122 M
Net income 2016 -126 M
Debt 2016 39,0 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 479x
EV / Sales 2016 27,9x
Capitalization 1 424 M
More Financials
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
11/09 LEXICON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
11/06DJLexicon, Sanofi Agree to Diabetes Drug Pact
11/06 LEXICON PHARMACEUTICALS : reports 3Q loss
11/06 Sanofi sees strong profit growth from 2018, to cut costs
10/29 LEXICON PHARMACEUTICALS : Cancer Patients Treated With Lexicon's Telotristat Eti..
10/19 LEXICON PHARMACEUTICALS : Cancer Patients Treated with Lexicon’s Telotrist..
10/15 LEXICON PHARMACEUTICALS : Announces Telotristat Etiprate Data To Be Presented At..
10/12 LEXICON PHARMACEUTICALS : Announces Telotristat Etiprate Data to be presented at..
More news
Sector news : Bio Therapeutic Drugs
11/25 AMGEN : First Biosimilar Biologics License Application For ABP 501 Submitted To ..
11/24 GILEAD SCIENCES : to Present at Two Upcoming Investor Conferences on Tuesday, De..
11/24 EXCLUSIVE : Shire prepares to make new bid for Baxalta - source
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/01 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
05/01 Lexicon Undervalued As It Approaches A Major Event
04/29 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q1 2015 Results - Earning..
04/29 Lexicon Pharmaceuticals EPS in-line, beats on revenue
03/20 Lexicon Pharmaceuticals - A Diamond In The Rough?
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends LEXICON PHARMACEU...
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions